Abstract: Phospholipids (PLs) are the target for the clearance of apoptotic cells, and for the innate defense against malignant cancers or microbial infections. Several types of receptors for PLs were described on T lymphocytes, but not yet on B lymphocytes. To detect PLs binding lymphocytes two assays were used: a-FITC labelled liposomes, b-Petri dish coated with different PLs. The phenotype of lymphocytes was determined by FACS, using anti-CD mAb and anti-Ig polyclonal antibodies. Human lymphocytes bind PLs, the binding ratio decreases in the order phosphatidylserine (PS), cardiolipin (CL), phosphatidylethanolamine, and phosphatidylcholine. In healthy blood donors (n=17), 29% of B lymphocytes, 17% of NK cells, 9% of TCD4 + , and 4% of TCD8 + bind PS. Among B cells, the binding ratio varies with the subset, 49% for naïve cells (sIgM + sIgD + ), 42% for sIgA + , and 15% for sIgG + B cells. PL binding was not affected by the CD5 phenotype of B lymphocytes, nor by the HIV status of the donors (n=16) or the presence in the sera of IgG anti-CL antibodies. Pretreatment of lymphocytes with proteases inhibited the binding of PL, suggesting that binding is due to surface proteins. For each type of lymphocytes the various kinds of surface proteins which bind lipids, pattern recognition receptors, surface immunoglobulins, the lipid antigen presenting molecules CD1, and the CD1-restricted lipid antigen reactive TCR of NKT cells, are discussed.
INTRODUCTION
In healthy cells, phosphatidylserine (PS) is located in the inner layer of the plasma membrane, and cardiolipin (CL) is exclusively situated in the inner mitochondrial membrane. Phosphatidylethanolamine (PE) and phosphatidylcholine (PC) are sharing between the inner leaflet and the outer leaflet of the plasma membrane. Disruption of membrane asymmetry is observed in platelet activation, aging cells, and during cell death by necrosis or apoptosis [1] [2] [3] [4] [5] . Membrane lipid scrambling is strongly correlated with evaginations of cell surface and shedding of small membrane vesicles [1] .
Externalization of PS is a hallmark of the changes in the cell surface during apoptosis. PS spot to the inner leaflet of the plasma membrane; when the cell undergoes apoptosis, it is liable on the outer leaflet. PS on apoptotic cells provides a signal that initiates cell engulfment [6, 7] . Translocated PS produces a ligand by which apoptotic or dead cells are recognized by phagocyte cells and lymphocytes; candidate proteins are suggested as a PS specific receptor expressed on the surface of phagocyte cells and lymphocytes [8] [9] [10] . Moreover, anti-phospholipid antibodies (aPL) bind apoptotic cells and might contribute to their elimination by mononuclear phagocytes; aPL were described in the antiphospholipid syndrome [1] .
Lymphocyte might be able to recognize the loss of plasma membrane asymmetry, and to bind specifically some PLs like PS and PE, then could contribute to the clearance of [10] [11] [12] [13] .
The aim of this study was to identify the lymphocytes subsets with the highest binding ratio for the PLs PS, PC, PE and CL, and to compare the binding ratios of patients with altered lymphocytes subsets, AIDS to healthy donors. For this purpose we developed two techniques for isolating and identifying lymphocytes binding phospholipids.
MATERIALS AND METHODS

Phospholipid Coated Petri Dish [14]
Cardiolipin (CL) from bovine heart, L-a-phosphatidyl-Lserine dipalmitoyl (PS), L-a-phosphatidylcholine (PC) from frozen egg yolk type XIII-E, or L-a-phosphatidylethanolamine dipalmitoyl (PE) (Sigma, Saint-Quentin Fallavier, France) were dissolved at 0.48 mg in 9 ml of ethanol (Carlo Erba, Val de reuil, France). 1.5 ml of the solution was used to coat a plastic Petri dish (35x10, Corning, NY, NY). An overnight incubation at 4°C was used to evaporate the solvent. The binding of lymphocytes to control Petri dishes increased when proteins were used to saturate the plastic. Therefore the Petri dishes were not saturated.
Phosphatidylserine Liposomes (PSL) Preparation [15, 16]
Solution of PS (300 g/ml) in chloroform (Carlo Erba) was evaporated in a glass tube. Then 50 l of 10 mg/ml fluorescein conjugated albumin (Sigma) and 950 l of PBS (bio-Mérieux, Marcy l'Etoile, France) were added on the phospholipid film; and sonicated for 15 minutes at 35 kHz on a Gen-probe sonicator (Elma-Hans Schmidbauer, Singen, Germany). FITC-albumin labelled liposomes were separated from free FITC-albumin by Sepharose 6B (Pharmacia, SaintQuentin en Yvelines, France) gel filtration chromatography. Liposomes with other PLs were prepared in the same technical conditions as PSL.
Antibodies
R-Phycoerythrin (RD1) conjugated anti-CD4 and anti-CD56, and tandem dye R-Phycoerythrin-Texas red (ECD) conjugated anti-CD3 and anti-CD19 mAb were purchased from Coulter-Immunotech, Margency, France. FITC conjugated affinity isolated goat F(ab')2 anti-human Ig(G, A, M or D) antibodies were purchased from Tago, Burlingame, CA.
Isolation of Lymphocytes and Analysis by Flow Cytometry [15]
Cells Isolation
Cell donors were healthy subjects (n=17) and AIDS patients (n=16). HIV infection and AIDS were diagnosed according to criteria of the CDC [17] . The study protocol was in accordance with the local ethical committee guidelines.
Peripheral blood mononuclear cells were isolated from EDTA anticoagulated blood (Vacutainer 7 ml plastic tubes, Beckton Dickinson, Le Pont de Claix, France) by centrifugation at 500g for 20 minutes at 20°C on a layer of Ficoll (d=1.077) (Eurobio, Les Ulis, France), then washed with RPMI medium (Gibco, Cergy Pontoise, France) and adjusted to 5x10 5 cells/ml.
Petri Dish and Liposomes Assays
In the assays with Petri dish coated with PL, 1 ml of cell suspension was layered on and incubated at room temperature for 30 min. After washing for three times, the adhering cells were harvested with a rubber policeman and washed in RPMI. Then the cells were labelled with mAb to CD antigens or affinity isolated goat F(ab')2 anti-human Ig(G, A, M or D) antibodies and analyzed on an Epics XL 4 colour flow cytometer (Beckman Coulter, Marseille, France).
In the assays with liposomes, 1 ml of cell suspension is mixed by very gentle rotation on a rotator (Carteau et Ots, Bagnolet, France) with 0.1 ml freshly prepared PSL for 15 min at room temperature; then washed with RPMI, stained with anti-CD mAb and analysed by flow cytometry.
Anti-Phospholipid Antibodies (aPL)
ELISA was used to detect aPL in the technical conditions that we previously described [13] .
Enzymatic Treatment of Lymphocytes
0.3 ml of cell suspension are incubated at room temperature with 28 g/ml of papain or 6 g/ml of proteinase K or 6 g/ml of trypsin (Sigma) for 10 min then washed with RPMI. The concentration of each protease was adjusted to obtain less than 5% of cell death, with blue trypan staining.
Isotype of Immunoglobulines in the Phosphatidylserine Affinity Column Eluates
Isolation of Plasma Membranes [18-20]
Lymphocyte cells (10 8 cells) are suspended in a hypotonic medium (e.g. 30 mM NaHCO3, pH 7), to be homogenized in a tight-fitting dounce homogenizer, inclusion in the suspension of 1 mM ZnCl2 stabilizes the plasma membranes, and then the pellet was obtained by centrifugation at 1000 g for 15 min.
200 ml of 20% dextran, 103 ml of 30% polyethyleneglycol (PEG) Carbowax 800, 33 ml of 0.2 M sodium phosphate pH 6.5 and 179 ml of distilled water are mixed and left at 4 °C for 24 hours to collect a top phase and bottom phase.
The pellet was resuspended in 10 ml of the upper phase, then 10 ml of lower phase is added to the suspension; and then the mixture was centrifuged at 2000 g for 15 min to collect plasma membranes at the interface of two phases.
Phosphatidylserine Affinity Column [21, 22]
Phosphatidylserine 10 mg (Sigma) and cholesterol 50 mg (Sigma) were dissolved in 1 ml of ethanol, mixed with 10 ml of acrylamide gel solution; then the mixture was incubated overnight at room temperature. The resulting gel was homogenized in gel particles, assembled into a column and equilibrated with PBS.
Plasma membranes diluted with 32 mls of PBS went through the column at 15 mls/hour. PBS is then infused through the column at 30 mls/hour, to get all the unbound plasma membranes. And then 35 mls of eluting buffers was passed through the column at 45 mls/hour. The samples were pooled, dialysed and concentrated.
The acrylamide gel solution contains 15% acrylamide, 5% bisacrylamide, 100 l of 140 mg/ml ammonium persulfate and 5 l of TEMED. The eluting buffer contains 0.1 M phosphate buffer 0.5 M NaCl pH 7.3 and 0.1 M glycine-HCl pH 2.5.
Screening of the Isotype of Immunoglobulins by Dot Blot [23]
Column eluate sample was deposited on a blotting membrane; after this the blotting membrane was incubated with antibodies conjugated to alkaline phosphatase (antiIgG, anti-IgD, anti-IgM) in a blocking solution for 2.5 hours at room temperature, then washed with washing solution. For revelation, the blotting membrane was incubated with BCIP/NBT solution for 3 min at room temperature, then washed with 1% acetic acid.
The washing solution (Sigma) contains 20 mM Tris-HCl, pH 7.5, 0.9% NaCl and 0.05% Tween 20. The blocking solution (Sigma) contains washing solution and 1% BSA. The BCIP/NBT solution (Sigma) contains 0.48 mM NBT (nitro blue tetrazolium), 0.56 mM BCIP (5-bromo-4-chloro-3-indolyl phosphate), 10 mM Tris-HCl, pH 9.2 and 59.3 mM MgCl2.
Statistics
The lymphocytes PL binding ratios were compared by a non parametric test (Kolmogorov-Smirnov) and Student's t test, using the Statework software.
RESULTS
Between 4-18% of healthy donor lymphocytes bind fluorescein labelled PS liposomes (PSL). Roughly similar results are obtained by flow cytometry or observation with fluorescence microscopy. By fluorescence microscopy, we do not observe any diffuse fluorescence on the surface of lymphocytes, thus we could exclude diffusion and passive fixation of fluorescein or fluorescein stained proteins (albumin or IgG) used for the labelling of PSL. The only fluorescence observed was in the PSL attached on the cell surface and in the cytoplasm of scarce mononuclear phagocytes ( Fig. 1) .
To compare the binding ratio of the lymphocytes according to the PLs (PS, CL, PE or PC), each of them was used to prepare liposomes or to coat Petri dishes. In 17 healthy donor lymphocytes, the binding ratios decrease in the order PS, CL, PE and PC (non parametric test p=0.02) (Fig. 2) . Binding to PC coated Petri dishes was similar to control Petri dishes.
The decrease of the binding ratios from PS, CL, PE to PC observed with whole lymphocyte population was confirmed with all the lymphocyte subpopulations studied, CD19 + CD5 -, CD19 + CD5 + , TCD3 + , TCD4 + , T CD8 + , and CD56 + (NK cells).
The PLs binding ratio varies from one lymphocyte subpopulation to another. In 17 healthy donor lymphocytes, the highest binding values for PSL were observed with B cells (CD19 + ) 29±29.5%, followed by NK (CD56 + ) 16 .6±10%. The percentage of cells binding PSL binding cells was 9±8% for TCD4 + , 8±3.7% for TCD3 + and 4±2% for TCD8 + (Fig. 3A-D) . Similar results were observed with PS coated Petri dishes. (Fig. 4) . Results were quite similar between PS and CL coated Petri dishes, and between CD5 + and CD5 -B lymphocyte lineages ( Table 1) . With an aim of seeing whether the alterations of the populations of lymphocytes could influence the PL binding ratios, AIDS patients' lymphocytes were tested. PS binding ratios of CD5 + or CD5 -B lymphocyte lineages of 16 AIDS patients were not different from healthy donors ( Table 1 and Fig. 5 ). Nor were different AIDS patients with IgG anticardiolipin antibodies (n=4) from patients without antibodies (n=8). Results were similar either when PS or CL was used for coating Petri dishes.
Pretreatment of lymphocytes with proteases decreased binding to PSL (Fig. 3E, F) or PS coated Petri dish. Average inhibition with 8 healthy donor lymphocytes was of 86% with proteinase K, 76% with papain, and 63% with trypsin. Stronger inhibition was obtained by increasing the concentration of proteases (see material and methods), but the dead cell ratio increased also. Inhibition of PL binding was observed in all lymphocyte subpopulations. These results suggest that a protein or a set of proteins on the plasma membrane of lymphocytes could bind PLs.
Lymphocyte plasma membranes were isolated and perfused through a PS affinity column. Eluted material was deposited like a dot on a nitrocellulose membrane. The dot membrane was incubated with alkaline phosphatase conjugated anti-isotype antibodies and then revealed with the substrate BCIP/NBT. The coloration of dots was dark with anti-IgD or anti-IgM, and pale with anti-IgG or anti-IgA (Fig. 6). 
DISCUSSION
Many investigations have been done to study the receptors binding PL; in macrophage various candidate proteins have been evoked in the binding of cells expressing PS, but the nature of the receptor(s) that mediate PS recognition remains unclear; scavenger receptors, a5ß3 integrin, CD36 and CD14 have been reported to bind PS [24] [25] [26] [27] . Class B scavenger receptors type I (SR-BI) and CD36 bind PS liposomes but not PC and PE liposomes [28] . SR-BI is a PS receptor which allows Sertoli cells to identify and phagocyte death cells [29] and CD36 represents a multifunctional adhesive receptor on a variety of cells such as monocytes and platelets. CD36 has been implicated in the removal of apoptotic or senescent cells [30] . A third receptor on macrophages, CD14, binds PS weaker than PI [31] . CD14 was involved in the recognition and phagocytosis of cells undergoing apoptosis [32] . A protein receptor on the surface of macrophages, fibroblasts and epithelial cells for phosphatidylserine-specific clearance of apoptotic cells and engulfment of apoptotic corpses was described [9, 33] . Phosphatidylserine receptor (PSR) was identified by monoclonal antibodies mAb 217 [9] . PSR was localized in the nucleus; mAb 217 antigen is not expressed on lymphoid cells although it is expressed on the various cells [34] . Mitchell et al. [34] exclude this PSR from a functional role in innate apoptotic cell recognition and engulfment; they suggest that the designation of this gene product as a PSR is inappropriate.
Based on binding studies, mutagenesis and a co-crystal structure, Freeman GJ et al. [10] concluded that TIM (T cell/transmembrane, immunoglobulin, and mucin) are pattern recognition receptors specialized for recognition of PS. They provide a functional repertoire regulating the immune response of T lymphocytes against cells or exosomes expressing PS. TIM-1, TIM-3, and TIM-4 all bind PS; in this binding PS penetrates to the pocket called MILIBS (metal ion-dependent ligand-binding site). Asn and Asp residues in the MILIBS coordinate with metal ions and PS. Asn and Asp residues are absent in TIM-2 therefore TIM-2 does not bind PS. 
TIM-1 is expressed on CD4 + T cells and T helper 2 cells. TIM-3 is expressed on CD4 + T cells, T-helper 1 cells, CD8 + T cells, NK cells, NKT cells, and at low levels on Th17 cells.
In contrast to TIM-1 and TIM-3, TIM-4 is not expressed on T cells but is expressed exclusively on antigen-presenting cells; TIM-3 is also expressed on mast cells, macrophages, monocytes and dendritic cells [10] . Except low levels of TIM-1, no other TIM was described on B lymphocytes [10] .
The CD1 family consists of five proteins (a-e) that are related to the MHC class I family. CD1 proteins have evolved as a separate lineage of antigen presenting molecules able to present microbial and self lipids to T lymphocytes. Crystal structures of mouse and human CD1d show how it binds and presents a diverse range of lipid ligands. The membrane distal 1 and 2 domains contain a hydrophobic ligand binding site that is comprised of two connected pockets, designated A' and F'. The A' pocket is filled by the lipid tail while the F' pocket is filled by the polar head [13] .
B cells express CD1 and hence have the potential to present lipid antigens to Natural killer T (NKT) cells, they do so at a level equivalent to 2-to 3-fold lower than that of dendritic cells (DC). B lymphocytes suppress DC-mediated iNKT and NK cell activation and cell-cell contact is essential for this effect [35] .
Activated and memory B cells express lower levels of CD1d compared with resting, naive, and marginal zone-like B cells. In vitro, CD1d is downregulated by all forms of B cell activation, CD1c expression and function also decrease following activation by CD40L alone, whereas activation via the BCR significantly upregulate CD1c, particularly on marginal zone-like B cells [36] . The higher PLs binding ratio of naïve B lymphocytes than memory or effector B lymphocytes that we observed might be explained by a difference in the density of CD1 on the cell membrane.
NKT cells are CD1d-restricted, lipid antigen-reactive T cells that express a limited array of T cell receptors (TCRs), with the an invariant chain (V 24-Ja18 in humans) paired with particular TCR-V (V 11 in humans). NKT cells are activated by microbial glycolipids as well as by self glycolipids or phospholipids such as phosphatidylinositol, phosphatidylglycerol, PE or PC [13, 37] . There is a growing body evidence to suggest that NKT cells have a powerful immunoregulatory potential against microbial or self antigens in autoimmune diseases.
The PLs binding ratios of human lymphocytes decrease in the order PS, CL, PE and PC. This binding might depend on the charge of the phospholipid head group, anionic PLs are bound better than zwiterionic PLs, or alternatively be PL specific. In a quantitative analysis of liposome-cell interaction the extent of liposome binding by human lymphocytes was 2-3 fold less than the extent by monocytes [38] . The binding of negatively charged PS/PC/cholesterol liposomes was several fold to an order of magnitude higher than that neutral PC/cholesterol liposomes. Maturation/ differentiation of monocytes in culture increases the binding ratio of negatively charged to neutral liposomes ratio from 5 to 30-40. In contrast, the lymphocytes did not show this dependency on the culture duration as this ratio in lymphocytes stayed around 10. The binding of PS-containing liposomes is mediated by binding sites that have strong affinity, comparable to or about an order of magnitude smaller than other known particle-cell interactions with specific receptors such as virus and lipoproteins binding to cells [38] . The proportion of B cell clones that might be committed to the production of aPL antibodies, though not exactly known, seems however relatively high, 21% of the primary lines of Epstein-Barr virus transformed human peripheral blood lymphocytes, produce IgG or IgM anti-cardiolipin antibodies [40] . Alternatively the higher density of CD1 on the membrane of virgin B lymphocytes than on the membrane of memory or effector B lymphocytes [36] might explain the difference in PLs binding.
No significant difference in PLs binding is observed between CD5 + and CD5 -B lymphocyte lineages. Because polyreactive natural autoantibodies are produced by the CD5 + B lymphocyte lineage, the membrane bound anti-PLs natural autoantibodies cannot be the explanation of the high ratio of naïve B cells binding to PLs.
B-1a (CD5 + ) cells producing natural IgM anti-PC antibodies were originally recognized because they lyse bromelain-treated mouse erythrocytes in a complementdependent plaque forming cell assay. These cells, although constituting only a minor fraction of B cells in spleen and lymph nodes of mice, represent the main B-cell population in the peritoneal and pleural cavities [41] . Up to 15% of peritoneal B-1a cells in all normal mouse bind PC. They produce most of the natural antibodies in serum and contribute significantly to the IgA producing plasma cells in the lamina propria of the gut. Half of the serum IgA and a significant amount of the spontaneously produced (natural) IgG in serum are produced by isotype-switched progeny of B-1a cells [42] . They participate in relatively few, antigen stimulated antibody responses, mostly those stimulated by Tindependent antigens. B-1b cells lack surface CD5, though they possess mRNA for CD5 [43] . B-1b or B-2 (CD5 -) cells are transiently induced to express CD5 in the follicular mantle zones of secondary lymphoid tissues [44] .
Though similarities are observed with our results specially the high proportion of naïve B lymphocytes binding PS, contradictions are multiple. No difference were found in avidity to PLs between CD5 + and CD5 -B cells, and PC was the PL with the lowest binding ratio. However in these studies realized with mouse lymphocytes, PS and PC were not systematically compared with regard to their affinity. Human IgM aPC has been recognized for several years, but information regarding aPC as antibodies to bromelain-treated healthy human erythrocytes is scant [45] . They have been associated with polyreactive natural autoantibodies [46] .
Wadee AA et al. [12] Indicated that PE and phosphatidylinositol (PI) bind actively and separately to lymphocytes, they described that the receptors for these two phospholipids on the surface of lymphocytes were trypsine and heat sensitive. Our results with protease treated lymphocytes suggest that a surface protein or a set of surface proteins bind PL. Moreover IgM and IgD were eluted from a PS affinity column perfused with lymphocytes plasma membranes fragments. The question arises of knowing who bind directly PS, IgM and IgD, or another membrane protein close or linked to membrane Ig. Such a protein might be the CD1 or a receptor for PS, perhaps a pattern recognition receptor specialized for recognition of PS similar to TIM receptors, with increased density on naïve B lymphocytes.
The TIM gene family plays a role in asthma, autoimmunity, tolerance and viral infection. In HIV + patients, TIM-3 is expressed on approximately 50% of CD8 + T cells against 28% in non HIV patients [10] . In contrast we observed similar PL binding by the B cell subsets in AIDS patients and non HIV control patients. HIV infection is associated with widespread abnormalities in the immune system, the destruction of TCD4 population being the major one. In these patients a high prevalence of antibodies to PL was reported, and we previously showed that anti-PC (zwiterionic PL) antibodies are found as frequent as anti-CL (anionic PL) antibodies [15] . However, PL binding ratios of B lymphocyte subsets of AIDS patients or patients with IgG anti-CL autoantibodies were not different from healthy donors. These contradictions could be explained by the fact that the majority of PL binding cells are naïve B cells which express CD1, a lipid presenting molecule, and these cells remain relatively constant whatever the immune status of the patient, including patients producing IgG anti-CL antibodies. Though this conclusion needs to be confirmed with more patients producing anti-CL antibodies, because in our study the number of patients included (n=4) was small.
In conclusion, binding to PLs was observed with all the lymphocyte subpopulations studied. Virgin B lymphocytes show the highest binding ratios to PLs. No difference in binding ratios was observed between CD5 + and CD5 -B lymphocyte lineages. Anionic PLs had stronger avidity than zwiterionic PLs in binding to lymphocyte surface proteins. For each type of lymphocytes various kinds of surface proteins bind lipids, pattern recognition receptors, surface immunoglobulins, the lipid antigen presenting molecules CD1, and the CD1-restricted lipid antigen reactive TCR of NKT. Does the subpopulation binding PS participate in removing or destroying senescent and apoptotic cells, malignant cancers, modulating the innate immunity against microbial infections or suppressing anti-PLs antibodies ? This question and the respective role of PLs binding receptors or antigen presenting molecules need to be further studied.
